APRE vs AMGN: Which Stock is Better?
Side-by-side comparison of Aprea Therapeutics Inc and Amgen Inc in 2026
APRE
Aprea Therapeutics Inc
$0.88
AMGN
Amgen Inc
$331.00
Key Metrics Comparison
| Metric | APRE | AMGN | Winner |
|---|---|---|---|
| Market Cap | $6.22M | $177.92B | AMGN |
| P/E Ratio | N/A | 25.57 | AMGN |
| EPS (TTM) | $N/A | $12.92 | AMGN |
| Revenue Growth | -1.0% | 0.1% | AMGN |
| Gross Margin | -1619.1% | 70.1% | AMGN |
Analyze APRE
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APRE or AMGN a better investment?
Comparing APRE and AMGN: Aprea Therapeutics Inc has a market cap of $6.22M while Amgen Inc has $177.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APRE and AMGN?
APRE (Aprea Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APRE or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APRE or AMGN?
AMGN has higher revenue growth at 0.1% vs -1.0% for APRE.
Which company is more profitable: APRE or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.1% compared to -1619.1% for APRE.
Which is the larger company: APRE or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $6.22M for APRE.
Should I buy APRE or AMGN in 2026?
Both APRE and AMGN have investment merit. APRE trades at $0.88 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APRE and AMGN stock?
Key differences: Market Cap ($6.22M vs $177.92B), P/E Ratio (N/A vs 25.6x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (-1619.1% vs 70.1%).